To confirm the involvement of the TGF-β2/Smad signaling pathway in KDM4C mediated effects in lung cancer, KDM4C and TGF-β2 were silenced with siRNAs and recombinant human TGF-β2 was added into KDM4C-depleted lung cancer cells. The gene discussed is KDM4C; the disease is lung cancer.